Life - Articles - Covid19 assessing Life Insurers financial strength ratings


DBRS Morningstar published a commentary titled “Assessing the Impact on Life Insurers' Financial Strength Ratings as the Coronavirus Crisis Unfolds,” which discusses some of the challenges in assessing life insurers’ ratings during the Coronavirus Disease (COVID-19) pandemic, and the potential rating implications.

 The key highlights include:

 (1) The global economic downturn and low-interest rate environment, as well as the heightened equity market volatility, credit default risk, and product risk, could all adversely affect life insurers' ratings.
 (2) In the short term, we are reviewing the factors in the building blocks that assess the risk profile, earnings ability, and capitalization scores.
 (3) The franchise strength and liquidity blocks assessments are not as susceptible to the current shocks; however, depending on the duration and severity of the impact of the coronavirus on the markets where the insurer operates, we will likely adjust the assessment of the remaining building blocks and factors.

 “Looking forward, there will be greater pressure to restore the capitalization building block, as well as an insurers' ability to remedy any significant deterioration within a reasonable time,” said Hema Singh, Vice President from the DBRS Morningstar Global Financial Institutions team.

 “DBRS Morningstar considers that companies with low levels of capital buffers and significant exposure to equity market volatility through their asset portfolio or product portfolios offerings could see their solvency position deteriorate quickly during the coronavirus pandemic.”
  

  

 Assessing the Impact on Life Insurers' Financial Strength Ratings as the Coronavirus Crisis Unfolds

Back to Index


Similar News to this Story

Businesses behind booming private healthcare sector
Insured admissions rise to 171,000 in Q1 2025 – the joint highest ever quarter. Over 70% of private health treatments now funded by Private Medical In
Weight loss drugs may reduce mortality 6.4 percent by 2045
Swiss Re's optimistic scenario estimates GLP-1 drugs could lead to a reduction in cumulative all-cause mortality in the US general population of
Everyday accidents prompt increase in hospital admissions
MetLife UK’s second Everyday Risk Report finds number of everyday accidents is on the rise. A&E visits increased 3.8%, while hospital admissions incre

Site Search

Exact   Any  

Latest Actuarial Jobs

Actuarial Login

Email
Password
 Jobseeker    Client
Reminder Logon

APA Sponsors

Actuarial Jobs & News Feeds

Jobs RSS News RSS

WikiActuary

Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.